Literature DB >> 11732485

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females.

K D MacDermot, A Holmes, A H Miners.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11732485      PMCID: PMC1734754          DOI: 10.1136/jmg.38.11.769

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  186 in total

1.  Fabry disease in genetic counseling practice: recommendations of the National Society of Genetic Counselors.

Authors:  Robin L Bennett; Kimberly A Hart; Erin O'Rourke; John A Barranger; Jack Johnson; Kay D MacDermot; Gregory M Pastores; Robert D Steiner; Ravi Thadhani
Journal:  J Genet Couns       Date:  2002-04       Impact factor: 2.537

2.  Anderson-Fabry disease in Austria.

Authors:  Matthias Lorenz; Anna-Christina Hauser; Margot Püspök-Schwarz; Peter Kotanko; Ingrid Arias; Herbert Zodl; Reinhard Kramar; Eduard Paschke; Till Voigtländer; Gere Sunder-Plassmann
Journal:  Wien Klin Wochenschr       Date:  2003-04-30       Impact factor: 1.704

Review 3.  Fabry disease, enzyme replacement therapy and the significance of antibody responses.

Authors:  Patrick B Deegan
Journal:  J Inherit Metab Dis       Date:  2011-10-25       Impact factor: 4.982

4.  Unravelling the mechanism of action of enzyme replacement therapy in Fabry disease.

Authors:  Younhee Ko; CheolHo Lee; Myeong Hee Moon; Geu-Ru Hong; Chong-Kun Cheon; Jin-Sung Lee
Journal:  J Hum Genet       Date:  2015-10-22       Impact factor: 3.172

Review 5.  Fabry disease: a rare cause of neuropathic pain.

Authors:  Marieke Biegstraaten; Gabor E Linthorst; Ivo N van Schaik; Carla E M Hollak
Journal:  Curr Pain Headache Rep       Date:  2013-10

6.  High prevalence of subclinical hypothyroidism in patients with Anderson-Fabry disease.

Authors:  A C Hauser; A Gessl; M Lorenz; T Voigtländer; M Födinger; G Sunder-Plassmann
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

7.  Improvement of Fabry Disease-Related Gastrointestinal Symptoms in a Significant Proportion of Female Patients Treated with Agalsidase Beta: Data from the Fabry Registry.

Authors:  William R Wilcox; Ulla Feldt-Rasmussen; Ana Maria Martins; Alberto Ortiz; Roberta M Lemay; Ana Jovanovic; Dominique P Germain; Carmen Varas; Katherine Nicholls; Frank Weidemann; Robert J Hopkin
Journal:  JIMD Rep       Date:  2017-05-17

8.  Depression in adults with Fabry disease: a common and under-diagnosed problem.

Authors:  A L Cole; P J Lee; D A Hughes; P B Deegan; S Waldek; R H Lachmann
Journal:  J Inherit Metab Dis       Date:  2007-11-12       Impact factor: 4.982

Review 9.  Enzyme replacement therapy of Fabry disease.

Authors:  Joe T R Clarke; R Mark Iwanochko
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

Review 10.  [Effect of enzyme replacement therapy (ERT) on renal function of patients with Fabry's disease].

Authors:  Thomas Thomaidis; Manfred Relle; Joerg Reinke; Michael Beck; Andreas Schwarting
Journal:  Med Klin (Munich)       Date:  2009-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.